- Exchange: Taiwan
- Sector: Consumer, Non-cyclical
- Industry: Biotechnology
- Sub-Industry: Medical-Biomedical/Gene
Snapshot for Adimmune Corp (4142)
| Open: | 40.25 | Day's Range: | 40.25 - 41.50 | Volume: | 1,360,870 |
|---|---|---|---|---|---|
| Previous Close: | 40.30 | 52wk Range: | 29.20 - 51.50 | 1-Yr Rtn: | +16.43% |
Key Statistics for 4142
| Current P/E Ratio (ttm) | - |
|---|---|
| Estimated P/E(-) | - |
| Relative P/E vs. TWSE | - |
| Earnings Per Share (ttm) | -3.4000 |
| Est. EPS | - |
| Est. PEG Ratio | - |
| Market Cap (M TWD) | 7,567.57 |
| Shares Outstanding (M) | 184.13 |
| 30 Day Average Volume | 5,479,949 |
| Price/Book (mrq) | - |
| Price/Sale (ttm) | - |
| Dividend Indicated Gross Yield | -% |
| Cash Dividend | - |
| Last Dividend | |
| 5 Year Dividend Growth | - |
| Next Earnings Announcement | 08/15/2013 |
mrq = Most Recent Quarter; ttm = Trailing Twelve Months
Income Statement for 4142
Company Profile & Key Executives for 4142
Adimmune Corp. is a human vaccine manufacturer. The company focuses on vaccines, diagnostics, and biological products. Adimmune manufactures vaccines such as the JEV, Tuberculin PPD, Tetanus toxoid, and influenza.
| Chan Chi-HsienChairman/President/CEO | Chang Che-WeiChief Financial Officer |
| Chang Chin-ChuanCOO/Head:R & D | Shen Ya-HuiChief Medical Officer |
Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.
Sponsored Financial Commentaries
Advertisement
Top Forex Trading Resources
-
4142 News
-
Industry News
Advertisement
- 1
- 2
- 3
- 4
- 5
Advertisement
Sponsored Links
Advertisements
Rate this Page